Latest News about PFE
Recent news which mentions PFE
Could Pfizer Beat Moderna in This New Billion-Dollar Market?
August 31, 2022
From Motley Fool
Should Pfizer Investors Be Worried About Moderna's Lawsuits?
August 31, 2022
From Motley Fool
Think Bitcoin Will Go Down? New ETF Bets Against Bitcoin Bull Michael Saylor And MicroStrategy
August 30, 2022
From Benzinga
Jill Biden tests negative for COVID after rare rebound infection, and U.S. cases are rising in 12 states
August 30, 2022
From MarketWatch
From Benzinga
Nasdaq Futures Fly As Wall Street Looks Set To Rebound From 2-Session Losses — Twitter, Best Buy And These Stocks In Focus
August 30, 2022
From Benzinga
After Double-Digit Percentage Declines, Are Vaccine Stocks Buys?
August 30, 2022
From Motley Fool
US Stock Futures Higher Ahead Of Economic Data, Fed Speakers
August 30, 2022
From Benzinga
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report
August 30, 2022
From Benzinga
From Benzinga
Better COVID Booster Stock: Moderna vs. Pfizer
August 29, 2022
From Motley Fool
Could This Move by Moderna Cost Pfizer Billions?
August 28, 2022
From Motley Fool
From Benzinga
3 Growth Stocks Poised to Skyrocket
August 27, 2022
From Motley Fool
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
From Benzinga
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany
August 26, 2022
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
August 26, 2022
From Benzinga
From Benzinga
From Motley Fool
Report finds Americans with long COVID losing billions in wages, and Moderna sues Pfizer and BioNTech over mRNA patents
August 26, 2022
From MarketWatch
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
August 26, 2022
From Benzinga
4 Blue-Chip Stocks to Steady Your Portfolio in 2022
August 26, 2022
From InvestorPlace
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 25, 2022
From Benzinga
Pfizer Outlines Positive Topline Data From Late-Stage Respiratory Syncytial Virus (RSV) Vaccine Study
August 25, 2022
From Benzinga
Better Dividend Stock: Pfizer or Verizon?
August 25, 2022
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.